Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
John Truelson

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

John Truelson, M.D.

 Personal Overview

Biographical Sketch Details of Research Personal Overview How to Contact
John Truelson
Name:
  John M. Truelson, M.D.
Endowed Title:
  American Airlines Professorship in Cancer Research
Academic Title:
  Associate Professor
Primary Appointment:
  Otolaryngology
School:
  Southwestern Medical School
Affiliations:
  Otolaryngology
The James W. Aston Clinical Building
Physician Profile:
  John Truelson, M.D.

 PERSONAL OVERVIEW
     
Positions and Employment
2005 University of Texas Southwestern Medical Center, Dallas, Texas; Residency Program Director, Department of Otolaryngology-Head & Neck Surgery
1995 University of Texas Southwestern Medical Center, Dallas, Texas; Associate Professor, Department of Otorhinolaryngology,
1987 The Good Shepherd Hospital, Bulape Hospital, Bibanga Hospital. Kasai Provinces Republique du Zaire, February ? May 1989.
1990 University of Texas Southwestern Medical Center, Dallas, Texas; Assistant Professor, Department of Otorhinolaryngology,
1990 Director, Division of Otorhinolaryngology-Head & Neck Surgery, John Peter Smith Hospital, Fort Worth, Texas
1990 Attending Staff. John Peter Smith Hospital, Fort Worth, Texas
1990 Parkland Memorial Hospital, Dallas, Texas
1990 St. Paul Medical Center, Dallas, Texas
1990 Dallas Veteran's Medical Center, Dallas, Texas
1990 Zale Lipshy University Medical Center, Dallas, Texas

Other Experience and Professional Memberships
1987 American Academy of Otolaryngology Head and Neck Surgery: Fellow,
1981 Texas Medical Association
1981 Dallas County Medical Society
1981 American Medical Association
1987 L'Ordre des Medecins (Zaire) 1990Reviewer, Peer Review and Abstract Section, Head & Neck
1990 Faculty Advisory Committee, University of Texas Southwestern Medical Center at Dallas
1991 Fee Complaint Committee, Dallas County Medical Society
1991 Admissions Committee Interviewer, University of Texas Southwestern Medical School at Dallas
1993 Blood Utilization Committee, Zale-Lipshy University Hospital
1993 Alternate Delegate, Texas Medical Association
1993 Monograph/Slide Lecture Series Subcommitee,AAO-HNS
1994 American College of Surgeons: Fellow,
1994 Clinical Executive Committee, Simmons Cancer Ctr.at University of Texas Southwestern Medical Center
1994 Steering Committee, Simmons Cancer Center at University of Texas Southwestern Medical Center
1994 Cancer Committee, Parkland Memorial Hospital
1995 American Society for Head & Neck Surgery: Fellow,
1995 Texas Association of Otolaryngology/HNS,
1995 Reviewer, Peer Review, Laryngoscope
1995 Campus Physicians Quality Home Health Care Service,
Zale-Lipshy University Hospital
1995 Program Chairman, Dallas Academy of Otolaryngology
1997 Treasurer, Dallas Academy of Otolaryngology 1999 President, Dallas Academy of Otolaryngology
1997 Operating Room Committee
Zale-Lipshy University Hospital
1997 Surgical Performance Improvement Committee
Parkland Memorial Hospital
1997 Reviewer, Peer Review, Otolaryngology-Head and Neck Surgery

Honors
1978 Bachelor of Sciences in Zoology with High Honors University of Texas, Austin,Texas
1978 Phi Beta Kappa: University of Texas, Austin, Texas

Research Support
Ongoing Research Support
1. Truelson (PI)
ZIL-301-A1. Evaluation of Tolonium Chloride (Toluidine Blue) Rinse in the Detection of Locally Recurrent or New Primary Oral Cavity Cancers and Cancer in Situ; Dates: October, 2000 to present

Completed Research Support
1. Truelson (PI)
414-94-2. Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Cisplatin/Epinephrine Injectable Gel (Product #5010) When Administered Intratumorrally for Achievement of Treatment Goals in Recurrent or Refractory Squamous Cell Carcinoma of the Head and Neck; Dates: 1997-2000
2. Truelson (PI)
Ad5CMV-p53 Phase II, Multi-Center, Open-Label Study to Evaluate the Effectiveness and Safety of
Administered by Intra-Tumoral Injections in 39 Patients with Recurrent Squamous Cell Carcinoma of the Head/Neck; Dates: Study Closed February, Dates: 1997-2000